Precision Oncology - Booth#2124

6 Things to Know to Get Your Cancer Drug Approved Faster

Did you know that the FDA is approving drug applications with biomarker data at much higher rates and with smaller sample sizes? And critical clinical trial goals like First Site Activated and First Patient In can be met in as little as 90 days if you tap into an established clinical trial network? Download our free oncology brief featuring 6 critical factors for accelerating approval, including real-world examples from successful oncology trials. And visit us at ASCO (booth 2124) to learn more.

PSI CRO: Where the Science of Delivery Meets the Art of Service

Consistently high performance takes a great deal of work. It's a delicate chemistry of science and art, mixed together with intense passion and a boundless work ethic, all woven into the very fabric of our culture.

But that's just who we are.

Ask any one of our employees what makes PSI different from other CROs, and most of them will tell you: it's our people. Add to that our proven feasibility and track record of 91% on-time enrollment in an industry that's plagued with delays, and you get the perfect chemistry for success.

See what's happening at psi-cro.com.

Chiltern - Booth #17111

In Complex Cancer Research, Experience Matters

During the last five years, Chiltern has conducted more than 500 studies, in both solid tumors and hematological malignancies, around the world. With experience including an average of over 10 years for each team member, you're working with a team that truly understands the complexities of your studies in all stages, phases and sizes.

We're building clinical development solutions around you - your program, your investigators, your patients. Chiltern. A Collaborative Approach Designed Around You^®. Learn More.